Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Insulin resistance is an essential feature of the metabolic syndrome that has been linked to rheumatoid arthritis (RA). Understanding how inflammation arising in one tissue affects the physiology and pathology of other organs remains an unanswered question with therapeutic implications for chronic conditions including obesity, diabetes mellitus, atherosclerosis, and RA. Adipokines may play a role in the development of atherogenesis in patients with RA. Biologic therapies, such as TNF-α antagonists, that block proinflammatory cytokines have beneficial effects on the insulin resistance that is often observed in patients with RA.

Citation

Iván Ferraz-Amaro, Carlos González-Juanatey, Raquel López-Mejias, Leyre Riancho-Zarrabeitia, Miguel A González-Gay. Metabolic syndrome in rheumatoid arthritis. Mediators of inflammation. 2013;2013:710928

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23431244

View Full Text